Drug Free Solution, Inc. (DSOL) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.07: the stock has moved about 93% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerDrug Free Solution, Inc. (DSOL) trades at $0.0004. Drug Free Solution, Inc. focuses on emotional wellness technology through its Living Breath Process. The company targets addiction prevention, self-help, and lifestyle markets with its programs, education, and services. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for DSOL: DSOL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DSOL against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
DSOL: this read rests on a single discipline (Munger composite) — the other council disciplines have no scored data yet.
How is this calculated? →Drug Free Solution, Inc. (DSOL) Healthcare & Pipeline Overview
Drug Free Solution, Inc. delivers emotional wellness technology, the Living Breath Process, targeting addiction prevention, self-help, and lifestyle markets. The company offers programs, education, and services through its Living Breath Series and aims to establish community wellness centers and support networks. It operates within the healthcare information services sector.
What Is the Investment Thesis for DSOL?
Drug Free Solution, Inc. presents a unique approach to emotional wellness through its Living Breath Process. The company's focus on addiction prevention and self-help markets positions it within a growing segment of the healthcare industry. Key value drivers include the expansion of its Living Breath Series programs and the establishment of community wellness centers. However, the company's small market capitalization of $0.00B and negative P/E ratio of -59.29 indicate financial challenges. Future success depends on the company's ability to effectively market its programs, secure partnerships, and demonstrate tangible results in reducing addiction and improving emotional wellness. The company's beta of 0.07 suggests low volatility relative to the market.
Based on FMP financials and quantitative analysis
DSOL Key Highlights
Market capitalization of $0.00B reflects the company's small size and limited market presence.
- P/E ratio of -59.29 indicates that the company is currently not profitable.
- Beta of 0.07 suggests low volatility compared to the overall market.
- The company's focus on emotional wellness aligns with growing demand for mental health solutions.
- The Living Breath Process represents a proprietary technology with potential for expansion into various markets.
Who Are DSOL's Competitors?
DSOL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| LEEEF Leef Brands Inc. | $0.19 | +1.84% | $38.8M | — |
| MGRX Mangoceuticals, Inc. | $0.39 | +1.51% | $6.63M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.49 | -1.32% | $9.00M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| SCNX Scienture Holdings, Inc. | $0.35 | -2.69% | $14.1M | — |
| BEAT HeartBeam, Inc. | $0.40 | -2.14% | $22.3M | — |
| EUDA EUDA Health Holdings Limited | $13.12 | +0.15% | $24.5M | — |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DSOL's Key Strengths?
Proprietary Living Breath Process technology.
- Focus on addiction prevention and emotional wellness.
- Potential for community-based partnerships.
- Experienced leadership team.
What Are DSOL's Weaknesses?
Small market capitalization and limited financial resources.
- Negative P/E ratio indicating lack of profitability.
- Limited brand recognition compared to larger competitors.
- Dependence on a single core technology.
What Could Drive DSOL Stock Higher?
Expansion of Living Breath Series programs to new markets and demographics.
- Establishment of community wellness centers in strategic locations.
- Partnerships with correctional facilities to implement the Living Breath Project.
- Development and launch of a digital platform for online delivery of the Living Breath Process (timeline: 1-2 years).
- Launch of corporate wellness programs based on the Living Breath Process (timeline: 1-2 years).
What Are the Key Risks for DSOL?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Competition from established players in the wellness market.
- Changes in regulations related to addiction treatment and mental health.
- Economic downturn affecting consumer spending on wellness products.
- Technological advancements disrupting the market.
- Limited financial resources and lack of profitability.
What Are the Growth Opportunities for DSOL?
- Expansion of the Living Breath Series: The company can expand its Living Breath Series of programs to reach a broader audience. This includes developing new products, educational materials, and services tailored to specific demographics and needs. The global self-help market is projected to reach $14 billion by 2027, providing a significant opportunity for growth. Timeline: Ongoing.
- Establishment of Community Wellness Centers: Drug Free Solution can establish community wellness centers in strategic locations to provide access to its Living Breath Process and related services. These centers can serve as hubs for community engagement and offer a range of wellness programs. The market for community-based wellness programs is growing, driven by increasing awareness of the importance of social support in mental health. Timeline: Ongoing.
- Partnerships with Correctional Facilities: The company can partner with correctional facilities to implement its Living Breath Project and reduce addiction and incarceration rates. This includes providing training, education, and support networks for inmates and staff. The market for correctional healthcare services is substantial, with significant potential for innovative programs that address addiction and mental health. Timeline: Ongoing.
- Digital Platform Development: Creating a digital platform to deliver the Living Breath Process online can significantly expand the company's reach and accessibility. This platform can offer virtual coaching, online courses, and interactive tools to support emotional wellness. The digital health market is experiencing rapid growth, with increasing adoption of telehealth and virtual wellness solutions. Timeline: 1-2 years.
- Corporate Wellness Programs: Offering corporate wellness programs based on the Living Breath Process can tap into the growing demand for employee mental health support. These programs can help reduce stress, improve productivity, and enhance employee well-being. The corporate wellness market is expanding, with companies increasingly investing in mental health benefits for their employees. Timeline: 1-2 years.
What Are DSOL's Competitive Advantages?
- Proprietary Living Breath Process technology.
- Focus on community-based wellness initiatives.
- Potential for partnerships with correctional facilities.
- Brand recognition within the emotional wellness market.
What Does DSOL Do?
Drug Free Solution, Inc., formerly known as Living Breath Project, Inc., is a lifestyle company founded to provide emotional wellness solutions. The company's core offering is the Living Breath Process, a three-step method incorporating self-analysis, breathwork, and language techniques. This process is designed to address various markets, including addiction prevention, self-help, emotional wellness, and general lifestyle enhancement. Drug Free Solution offers the Living Breath Series, a suite of programs, products, education, and services centered around this proprietary process. The company's Living Breath Project aims to establish community wellness centers, wellness homes, and correctional facility support networks. These initiatives combine the company's offerings to reduce addiction and incarceration rates in the United States. Incorporated in January 2014, Drug Free Solution, Inc. is based in El Segundo, California, and continues to develop and expand its reach within the emotional wellness market.
What Products and Services Does DSOL Offer?
- Delivers proprietary emotional wellness technology known as Living Breath Process.
- Offers a three-step process combining self-analysis, breath, and language.
- Targets addiction/prevention, self-help, emotional wellness, and lifestyle markets.
- Provides the Living Breath Series of programs with products, education, and services.
- Focuses on creating community wellness centers and wellness homes.
- Establishes correctional facility support networks and centers.
- Aims to diminish addiction and incarceration rates in the United States.
How Does DSOL Make Money?
- Sales of Living Breath Series programs, products, and services.
- Revenue from training and education programs related to the Living Breath Process.
- Partnerships with community wellness centers and correctional facilities.
- Potential revenue from corporate wellness programs.
What Industry Does DSOL Operate In?
Drug Free Solution, Inc. operates within the healthcare information services sector, which is experiencing growth due to increasing awareness of mental health and the demand for accessible wellness solutions. The market is competitive, with numerous companies offering various approaches to emotional wellness and addiction prevention. Competitors include companies like AHGIF (American Green, Inc.), CBSTF (Cannabics Pharmaceuticals Inc.), CYYNF (Canna-Global Acquisition Corp), ITHUF (Isracann Biosciences Inc.), and LEEEF (Laredo Oil Inc.). Drug Free Solution differentiates itself through its proprietary Living Breath Process and its focus on community-based wellness initiatives.
Who Are DSOL's Key Customers?
- Individuals seeking addiction prevention and self-help solutions.
- Community wellness centers and organizations.
- Correctional facilities and support networks.
- Corporations looking to improve employee wellness.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 45 |
| 2026-08-26 | 45 |
| 2026-08-29 | 45 |
| 2026-09-01 | 45 |
| 2026-09-04 | 45 |
| 2026-09-07 | 45 |
| 2026-09-10 | 45 |
What changed?
The score has stayed at 45.
Over the same 18 days the stock moved +0.0%.
Company Profile
Drug Free Solution, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in El Segundo, US. The company is led by CEO Jessica Bass. DSOL has traded publicly since 2012.
Key Financial Metrics
Return on equity for Drug Free Solution, Inc. stands at 2.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -12.7%, showing how much profit it generates from its asset base. A current ratio of 0.04 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -11.8%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Drug Free Solution, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
DSOL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Proprietary Living Breath Process technology.
- Focus on addiction prevention and emotional wellness.
- Potential for community-based partnerships.
- Experienced leadership team.
Bear Case
- Small market capitalization and limited financial resources.
- Negative P/E ratio indicating lack of profitability.
- Limited brand recognition compared to larger competitors.
- Dependence on a single core technology.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
DSOL Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
DSOL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DSOL.
Price Targets
Wall Street price target analysis for DSOL.
DSOL MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for DSOL; grades run from A+ (80-100) to F (below 30).
Leadership: Jessica Bass
CEO
Jessica Bass serves as the CEO of Drug Free Solution, Inc. Her background includes experience in the wellness and lifestyle sectors. She has a track record of developing and implementing innovative programs focused on emotional well-being and addiction prevention. Her expertise lies in creating community-based initiatives and partnerships to promote holistic health. She is committed to expanding the reach of the Living Breath Process and making it accessible to a wider audience.
Track Record: Under Jessica Bass's leadership, Drug Free Solution, Inc. has focused on expanding its Living Breath Series programs and establishing partnerships with community organizations. She has overseen the development of new educational materials and services related to the Living Breath Process. Her strategic decisions have aimed to increase the company's visibility and impact within the emotional wellness market.
DSOL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Drug Free Solution, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in DSOL.
- Low trading volume and wide bid-ask spread can lead to price volatility.
- The OTC Other tier indicates a higher risk of fraud or manipulation.
- Lack of regulatory oversight compared to major exchanges.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue streams and profitability.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- The company has a registered business address in El Segundo, California.
- The company has a CEO (Jessica Bass) with a background in the wellness sector.
- The company has a proprietary technology (Living Breath Process).
- The company has been in operation since 2014 (formerly Living Breath Project, Inc.).
DSOL Healthcare Stock FAQ
Is DSOL a good stock?
Stock Expert AI does not rate DSOL buy, sell or hold. Drug Free Solution, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for DSOL?
The main risks for Drug Free Solution, Inc. include its limited financial resources, lack of profitability, and competition from established players in the wellness market.
What are the key factors to evaluate for DSOL?
Evaluate DSOL on fundamentals, analyst consensus, and risk factors. Drug Free Solution, Inc. presents a unique approach to emotional wellness through its Living Breath Process. Not financial advice.
How frequently does DSOL data refresh on this page?
DSOL's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven DSOL's recent stock price performance?
Drug Free Solution, Inc. (DSOL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary Living Breath Process technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DSOL overvalued or undervalued right now?
Drug Free Solution, Inc. (DSOL) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of DSOL?
Yes, most major brokerages offer fractional shares of Drug Free Solution, Inc. (DSOL) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track DSOL's earnings and financial reports?
Drug Free Solution, Inc. (DSOL) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for DSOL earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company descriptions and limited financial data.
- OTC market data may be less reliable than data from major exchanges.